112 related articles for article (PubMed ID: 18219357)
1. Photodynamic therapy for central serous chorioretinopathy using a reduced dose of verteporfin.
Williams MA; Mulholland C; Silvestri G
Can J Ophthalmol; 2008 Feb; 43(1):123. PubMed ID: 18219357
[No Abstract] [Full Text] [Related]
2. Half-dose verteporfin photodynamic therapy for acute central serous chorioretinopathy: one-year results of a randomized controlled trial.
Chan WM; Lai TY; Lai RY; Liu DT; Lam DS
Ophthalmology; 2008 Oct; 115(10):1756-65. PubMed ID: 18538401
[TBL] [Abstract][Full Text] [Related]
3. Correspondence.
Narula R; Tibra NK; Narayanan R
Retina; 2009 Jun; 29(6):867; author reply 867-8. PubMed ID: 19516125
[No Abstract] [Full Text] [Related]
4. Photodynamic therapy in chronic central serous chorioretinopathy.
Battaglia Parodi M; Da Pozzo S; Ravalico G
Retina; 2003 Apr; 23(2):235-7. PubMed ID: 12707605
[No Abstract] [Full Text] [Related]
5. Safety enhanced photodynamic therapy for chronic central serous chorioretinopathy: one-year results of a prospective study.
Chan WM; Lai TY; Lai RY; Tang EW; Liu DT; Lam DS
Retina; 2008 Jan; 28(1):85-93. PubMed ID: 18185143
[TBL] [Abstract][Full Text] [Related]
6. Chronic central serous chorioretinopathy: photodynamic therapy.
Taban M; Boyer DS; Thomas EL; Taban M
Am J Ophthalmol; 2004 Jun; 137(6):1073-80. PubMed ID: 15183792
[TBL] [Abstract][Full Text] [Related]
7. Indocyanine green angiography-guided photodynamic therapy for treatment of chronic central serous chorioretinopathy: a pilot study.
Shanmugam PM; Agarwal M
Retina; 2004 Dec; 24(6):988-9; author reply 989. PubMed ID: 15580009
[No Abstract] [Full Text] [Related]
8. Safety enhanced photodynamic therapy with half dose verteporfin for chronic central serous chorioretinopathy: a short term pilot study.
Lai TY; Chan WM; Li H; Lai RY; Liu DT; Lam DS
Br J Ophthalmol; 2006 Jul; 90(7):869-74. PubMed ID: 16597666
[TBL] [Abstract][Full Text] [Related]
9. Current and future role of photodynamic therapy in chronic central serous chorioretinopathy.
Azad RV; Rani A; Pal N; Chandra P; Sharma YR
Am J Ophthalmol; 2005 Feb; 139(2):393-4; author reply 394. PubMed ID: 15734027
[No Abstract] [Full Text] [Related]
10. Fluorescein angiography-guided photodynamic therapy with half-dose verteporfin for chronic central serous chorioretinopathy.
Koytak A; Erol K; Coskun E; Asik N; Öztürk H; Özertürk Y
Retina; 2010; 30(10):1698-703. PubMed ID: 20539254
[TBL] [Abstract][Full Text] [Related]
11. Indocyanine green angiography-guided photodynamic therapy for treatment of chronic central serous chorioretinopathy: a pilot study.
Yannuzzi LA; Slakter JS; Gross NE; Spaide RF; Costa D; Huang SJ; Klancnik JM; Aizman A
Retina; 2003 Jun; 23(3):288-98. PubMed ID: 12824827
[TBL] [Abstract][Full Text] [Related]
12. Photodynamic therapy for chronic central serous chorioretinopathy.
Cardillo Piccolino F; Eandi CM; Ventre L; Rigault de la Longrais RC; Grignolo FM
Retina; 2003 Dec; 23(6):752-63. PubMed ID: 14707823
[TBL] [Abstract][Full Text] [Related]
13. Quantification of metamorphopsia in chronic central serous chorioretinopathy after half-dose verteporfin photodynamic therapy.
Fujita K; Imamura Y; Shinoda K; Matsumoto CS; Mizutani Y; Mizota A; Yuzawa M
Retina; 2014 May; 34(5):964-70. PubMed ID: 24406387
[TBL] [Abstract][Full Text] [Related]
14. Improvement in multifocal electroretinography after half-dose verteporfin photodynamic therapy for central serous chorioretinopathy: a randomized placebo-controlled trial.
Wu ZH; Lai RY; Yip YW; Chan WM; Lam DS; Lai TY
Retina; 2011; 31(7):1378-86. PubMed ID: 21836413
[TBL] [Abstract][Full Text] [Related]
15. Photodynamic therapy for focal retinal pigment epithelial leaks secondary to central serous chorioretinopathy.
Ober MD; Yannuzzi LA; Do DV; Spaide RF; Bressler NM; Jampol LM; Angelilli A; Eandi CM; Lyon AT
Ophthalmology; 2005 Dec; 112(12):2088-94. PubMed ID: 16325707
[TBL] [Abstract][Full Text] [Related]
16. Prognostic factors related to photodynamic therapy for central serous chorioretinopathy.
Moon JW; Yu HG; Kim TW; Kim HC; Chung H
Graefes Arch Clin Exp Ophthalmol; 2009 Oct; 247(10):1315-23. PubMed ID: 19421764
[TBL] [Abstract][Full Text] [Related]
17. Retinal sensitivity after photodynamic therapy with half-dose verteporfin for chronic central serous chorioretinopathy: short-term results.
Fujita K; Yuzawa M; Mori R
Retina; 2011 Apr; 31(4):772-8. PubMed ID: 20890236
[TBL] [Abstract][Full Text] [Related]
18. COMPARISON OF HALVING THE IRRADIATION TIME OR THE VERTEPORFIN DOSE IN PHOTODYNAMIC THERAPY FOR CHRONIC CENTRAL SEROUS CHORIORETINOPATHY.
Shiode Y; Morizane Y; Kimura S; Hosokawa M; Kawata T; Doi S; Hosogi M; Fujiwara A; Shiraga F
Retina; 2015 Dec; 35(12):2498-504. PubMed ID: 26035398
[TBL] [Abstract][Full Text] [Related]
19. Photodynamic therapy for acute central serous chorioretinopathy: the safe effective lowest dose of verteporfin.
Zhao MW; Zhou P; Xiao HX; Lv YS; Li CA; Liu GD; Li XX
Retina; 2009 Sep; 29(8):1155-61. PubMed ID: 19629018
[TBL] [Abstract][Full Text] [Related]
20. [Low dose photodynamic therapy for chronic central serous chorioretinopathy].
Cervera E; Montero J; Torralba C; Palomares P; Hernández M
Arch Soc Esp Oftalmol; 2008 Sep; 83(9):525-6. PubMed ID: 18803123
[No Abstract] [Full Text] [Related]
[Next] [New Search]
